Regeneron logo

Regeneron

North America, New York, United States, Tarrytown

Description

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.

Investor Profile

Regeneron has backed more than 9 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series B (22%)
  • Post Ipo Equity (22%)
  • Series C (22%)
  • Series A (11%)
  • Series G (11%)
  • Corporate Round (11%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma
  • Bioinformatics
  • Cloud Computing
  • Software
  • Life Science
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Regeneron frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Avalon Ventures
North America, California, United States, La Jolla
Co-Investments: 1
Frazier Life Sciences
North America, California, United States, Menlo Park
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
Lightspeed Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 1
J.P. Morgan Asset Management
North America, New York, United States, New York
Co-Investments: 1
B
Europe, Castilla-La Mancha, Spain, Tórtola
Co-Investments: 1
Pappas Capital
North America, North Carolina, United States, Durham
Co-Investments: 1

Which angels does Regeneron often collaborate with?

HH
North America, Iowa, United States, Adel
Shared Deals: 1

What are some of recent deals done by Regeneron?

Truveta

Bellevue, Washington, United States

Truveta is a healthcare data platform that provides EHR data for scientific research.

AnalyticsData ManagementHealth Care
Series CJan 13, 2025
Amount Raised: $320,000,000
Enlaza Therapeutics

La Jolla, California, United States

Enlaza Therapeutics is a biotechnology research company.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AApr 30, 2024
Amount Raised: $100,000,000
Sonoma BioTherapeutics

South San Francisco, California, United States

Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.

BiotechnologyLife ScienceTherapeutics
Corporate RoundMar 28, 2023
Amount Raised: $30,000,000
2seventy bio

Cambridge, Massachusetts, United States

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Post Ipo EquityJan 6, 2023
Amount Raised: $20,000,000
Vyriad

Rochester, Minnesota, United States

Vyriad is a clinical stage biopharmaceutical company.

Biotechnology
Series BMay 17, 2022
Amount Raised: $29,500,000
DNAnexus

Mountain View, California, United States

DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery.

BioinformaticsBiotechnologyCloud ComputingMedicalSoftware
Series GJun 9, 2020
Amount Raised: $100,000,000
Adicet Bio

Redwood City, California, United States

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

BiopharmaBiotechnologyHealth CareMedical
Series BSep 2, 2019
Amount Raised: $80,000,000
Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityApr 8, 2019
Amount Raised: $800,000,000
Decibel Therapeutics

Cambridge, Massachusetts, United States

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

BiotechnologyMedical DeviceTherapeutics
Series CJun 19, 2018
Amount Raised: $55,000,000